Mohammed Amali

Mohammed Amali is a Senior Lecturer at the University of Chester's Chester Medical School, serving as BSc Pharmacology Programme Lead. He holds a PhD in Pharmacology from the University of Liverpool (2015), MSc in Pharmacology from Obafemi Awolowo University (2010), and Bachelor of Pharmacy from University of Jos (2003).

• Education: PhD (University of Liverpool), MSc (Obafemi Awolowo University), BPharm (University of Jos)

His research focuses on drug hypersensitivity and natural product drug discovery, with 14 publications spanning pharmacological evaluation of medicinal plants, drug allergy mechanisms, and pharmaceutical formulation development. Recent work explores Datura metel's neuropharmacological potential and Terminalia macroptera's analgesic properties.

Publication trends show expertise in in vivo pharmacological models, molecular docking analysis, and drug-protein interaction studies. Key journals include Journal of Ethnopharmacology, Allergy, and Chemical Papers.

Scientific Awards:

• Fellowship of the Higher Education Agency (FHEA) - 2024

Teaching: Module Leader for Immunology (MD5026), Principles of Pharmacology and Toxicology (MD5029), and Medicinal Chemistry of Natural Products (MD5030). Participates in 10+ modules across cell biology, research methods, and clinical immunology.

Grants: Currently leads a Santander Universities-funded project (2023-2024) on Toxicity assessment of Natural and Synthetic Drugs used in Inflammation management.